Ready to see more hidden risks—and reveal more opportunities?
Medical Data is a game-changer. Get in touch to learn more.
Irix
Medical Data
It’s not just condition detection—it’s condition interpretation. Instantly.
See more stubbornly hidden conditions like cancer, tobacco use, heart attacks, and hospitalizations. And that means fewer labs, exams, and APS orders.
We scour real-time medical claims records for reality-based evidence of applicant risk. This data is aggregated from a variety of provider encounters beyond the primary physician—emergency rooms, substance abuse and tobacco treatment facilities, mental health centers, specialty clinics, you name it—including those that don’t have EHR systems or integrate with HIEs. Then we deliver FCRA-actionable interpretation of that data through the Irix Rules Engine for instant underwriting decisions, shearing weeks and dollars off outmoded workflows.
What you may be missing without Medical Data
Medical Data finds serious red flags that are all too often overlooked or can’t be found in lab analyses, exam reports, and attending physician statements. And when combined with Prescription Data, it reveals tobacco use in 16.8% of all hits.
- Substance use disorders and overdoses
- High-risk psychiatric conditions and suicide ideation
- Inpatient chemotherapies, expensive biologics, and other drugs not found in prescription histories
- Hospitalizations and heart attacks
- Other serious health conditions
- Tobacco use and history
See more risks on the condition spectrum with Medical Data.
With this newfound vision, carriers who use Medical Data report drastic decreases in APS orders, leaps in underwriting gains, and unprecedented confidence in their policy decisions.
Medical Data has transformed our lower face-amount business. It’s cut our APS orders nearly in half and slashed days off turnaround times. But it isn’t just faster; it’s cleaner and more concise than an APS. And when we do need one, Medical Data directs us to the right practitioner. The efficiencies and ROI are undeniable. We’re very impressed.”"
Lee Janecek
Vice President and Chief Underwriter,
Woodmen Life
A big part of our business is in the middle market of $250,000 to $500,000. A lot of that has to be simplified issue; you have to be as efficient as possible because there’s just not enough profit to cover fixed costs. At the same time, you have to guard against adverse selection. Without Medical Data, we couldn’t do it.”"
Jim Lucas
Senior Vice President and Chief Actuary,
AAA Life Insurance
Request a demo
Related topics
Webinar
State of the Data 2025: Irix Prescription Data
The product that launched a category remains central to your plans for innovation, growth, and business continuity.
Read more
White Paper
Those applicants you declined? Their mortality matters more than you think
Partner Re makes clever use of Irix® Risk Score to test industry assumptions about decline mortality.
Read more
Article
Six planes down: The magnitude of nicotine’s impact on mortality
Is it time to rethink tobacco underwriting guidelines?
Read more